These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11079599)

  • 1. Tc-99m MDP thyroid uptake in a patient with a large nontoxic goiter.
    Riedy G; Adler L
    Clin Nucl Med; 2000 Nov; 25(11):929-30. PubMed ID: 11079599
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidental thyroid Tc-99m methylene diphosphonate (MDP) uptake in a patient affected by polynodular goiter at bone scintigraphy.
    Bertagna F; Bosio G; Giubbini R
    Nucl Med Rev Cent East Eur; 2009; 12(2):81-2. PubMed ID: 20235059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extraosseous 99mTc-MDP uptake in mediastinal thyroid goiter: two case reports.
    Garty I; Rosen G; Risescu J
    Eur J Nucl Med; 1984; 9(11):521-4. PubMed ID: 6240402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of Tc-99m and I-131 thyroid imaging in clinical application].
    Huang MJ; Wang PW; Tzen KY; Huang BY
    Taiwan Yi Xue Hui Za Zhi; 1982 Jul; 81(7):951-8. PubMed ID: 6958817
    [No Abstract]   [Full Text] [Related]  

  • 5. Uptake of Tc-99m sestamibi and Tc-99m MDP in anaplastic carcinoma of the thyroid (nondiagnostic CT and ultrasound scans).
    Montes TC; Muñoz C; Rivero JI; Mota JA; Pustilnik N; Garcia F
    Clin Nucl Med; 1999 May; 24(5):355-6. PubMed ID: 10232478
    [No Abstract]   [Full Text] [Related]  

  • 6. Altered biodistribution of Tc-99m MDP in a uremic and severely malnourished patient supported with enteral nutritional feeding.
    Arslan N; Ilgan S; Karaĉalioğlu AO; Oztürk E; Bayhan H
    Clin Nucl Med; 1999 Dec; 24(12):993-4. PubMed ID: 10595491
    [No Abstract]   [Full Text] [Related]  

  • 7. Does radioiodine treatment change the methylene diphosphonate uptake in a toxic thyroid nodule on bone scintigraphy?
    Mulazimoglu M; Karyagar S; Saglampinar S; Ozpacaci T
    Clin Nucl Med; 2008 Oct; 33(10):731-3. PubMed ID: 18806586
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of an iodine restricted including no sea foods diet, on technetium-99m thyroid scintigraphy: a neglected issue in nuclear medicine practice.
    Javadi H; Neshandarasli I; Mogharrabi M; Jalallat S; Nabipour I; Assadi M
    Hell J Nucl Med; 2012; 15(1):40-2. PubMed ID: 22413111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked thyroid uptake of thallium-201 in patients with goiter: case report.
    Fukuchi M; Hyodo K; Tachibana K; Nishikawa A; Kido A; Nagai K
    J Nucl Med; 1977 Dec; 18(12):1199-201. PubMed ID: 606744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of color-coded Doppler sonography in the differential diagnosis of nodular thyroid gland changes].
    Klemenz B; Wieler H; Kaiser KP
    Nuklearmedizin; 1997 Oct; 36(7):245-9. PubMed ID: 9441284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple brown tumors in parathyroid carcinoma mimicking metastatic bone disease.
    Pai M; Park CH; Kim BS; Chung YS; Park HB
    Clin Nucl Med; 1997 Oct; 22(10):691-4. PubMed ID: 9343725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
    Kumar V; Kumar D; Howman-Giles RB; Little DG
    Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited sensitivity of parathyroid imaging with (99m)Tc-sestamibi/(123)I subtraction in an endemic goiter area.
    Rink T; Schroth HJ; Holle LH; Garth H
    J Nucl Med; 2002 Sep; 43(9):1175-80. PubMed ID: 12215555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of thyroid volume and goiter measured by means of ultrasonography and SPECT with use of 131I and 99m)c in smokers and non-smokers.
    Gierach M; Gierach J; Junik R
    Endokrynol Pol; 2009; 60(6):437-42. PubMed ID: 20041360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interference factors in the in vivo diagnosis of the thyroid].
    Anger K; Funke G; Lagemann K
    Nuklearmedizin; 1985 Feb; 24(1):7-11. PubMed ID: 2582373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tc-99m sestamibi thyroid imaging in patients on chronic amiodarone treatment: a comparison with Tc-99m pertechnetate imaging.
    Oki GC; Zantut-Wittmann DE; de Oliveira Santos A; Guariento MH; Tambascia MA; de Almeida EA; Amorim BJ; Lima MC; Etchebehere EC; Camargo EE; Ramos CD
    Clin Nucl Med; 2010 Apr; 35(4):223-7. PubMed ID: 20305407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualization of hepatic metastases of medullary thyroid carcinoma on Tc-99m MDP bone scintigraphy.
    Ali I; Johns W; Gupta SM
    Clin Nucl Med; 2006 Oct; 31(10):611-3. PubMed ID: 16985365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse discordant scintigraphy in diffuse goiter.
    Huiskes AW; De Klerk JM; Zelissen PM; Van Rijk PP; Van Isselt JW
    Clin Nucl Med; 1998 Sep; 23(9):588-90. PubMed ID: 9735979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tc-99m MDP scan in medullary carcinoma of the thyroid with bone marrow invasion.
    Turpin S; Villeneuve H
    Clin Nucl Med; 1998 Jun; 23(6):389-90. PubMed ID: 9619333
    [No Abstract]   [Full Text] [Related]  

  • 20. Tc-99m MDP uptake in primary breast lymphoma.
    Goyal M; Bang D
    Clin Nucl Med; 1998 Sep; 23(9):614-5. PubMed ID: 9735986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.